Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. MSFT
3. META
4. COST
5. SPY
6. MU
7. RMR
8. LEVI
9. RXT
10. AAPL

Go back to Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance

Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 11c

May 4, 2022 4:13 PM EDT

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q1 EPS of $3.73, $0.11 worse than the analyst estimate of $3.84. Revenue for the quarter came in at $813.7 million versus the consensus estimate of $852.75 million.

GUIDANCE:

Jazz Pharmaceuticals raises FY2022 revenue to $3.5-3.7 billion, versus the consensus... More